| Financial Year |
March 31 2023 |
| Monetary Funds |
226,991,885.20 |
| Held-for-trading Financial Assets |
96,709.23 |
| Notes Receivable |
6,479,057.02 |
| Accounts Receivable |
151,773,764.78 |
| Advances to Suppliers |
1,722,462.91 |
| Other Receivables |
5,984,149.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
188,703,657.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
490,011.28 |
| Total Current Assets |
656,975,430.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,860,892.90 |
| Investment Properties |
-- |
| Fixed Assetes |
498,559,628.33 |
| Under-construction Projects |
204,289,563.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,467,220.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
378,211.03 |
| Deferred Income Tax Assets |
13,988,342.35 |
| Other Non-Current Assets |
29,375,490.56 |
| Sub-Total of Non-Current Assets |
906,332,047.99 |
| Total Assets |
1,563,307,478.21 |
| Short-Term Loans |
93,102,699.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,430,000.00 |
| Accounts Payable |
68,408,194.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,571,959.16 |
| Taxes Payable |
7,710,414.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,286,463.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
198,072.60 |
| Other Current Liabilities |
166,800.00 |
| Sub-Total of Current Liabilities |
239,015,048.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,143,715.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,940,311.79 |
| Total Liabilities |
270,955,360.14 |
| Paid-In Capital(Or Share Stock) |
146,880,000.00 |
| Capital Surplus |
808,516,731.29 |
| Surplus Reserve |
43,447,633.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
293,770,882.70 |
| Minority Stockholder's Interest |
-326,649.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,292,678,767.40 |
| Owner's Equity（Stockholder's Equity） |
1,292,352,118.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,563,307,478.21 |
